New Targets and Modalities in Fibrosis

//New Targets and Modalities in Fibrosis
Loading Events
This event has passed.
Metrion Biosciences’ Sales and Marketing Manager, Dr Sophie Rose will be attending the ELRIG networking event, ‘New Targets and Modalities in Fibrosis’, to be hosted at Vertex Pharmaceuticals in Oxford from 5.30-8.30pm on 18th September 2019.
Sophie will be available to provide an overview of Metrion’s ion channel screening services and to answer any questions.
Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge biocluster, one of Europe’s largest bioscience research hubs. Our state of the art laboratories at Granta Park house high quality facilities for native and engineered cell line and induced pluripotent stem cell culture, a comprehensive suite of automated patch clamp platforms, multiple manual patch clamp rigs, fluorescence-based screening capability and laboratory data management and reporting systems. Our company is focused upon delivering a range of high quality ion channel drug discovery services. We provide highly skilled electrophysiology screening services to support client medicinal chemistry optimisation programmes, CiPA compliant cardiac safety profiling assays, neuroscience assays and translational assays. We combine in depth target class knowledge and high quality screening assays with highly experienced and collaborative drug discovery managers to keep your research focused upon meeting both objectives and timelines. Our team has successfully delivered many projects on behalf of our clients from one-off screening projects to fully integrated drug discovery programmes delivering clinical candidates.